未来科学城医药产业集群添新活力

Core Viewpoint - The establishment of the new office and laboratory for Jenda Jiuzhou in the Zhongguancun Life Science Park Phase III signifies a significant step in enhancing research and development capabilities in the field of brain science and related innovations [1] Group 1: Company Development - Jenda Jiuzhou, founded by renowned neuroscientist Luo Minmin, aims to translate innovative achievements in brain science into practical applications [1] - The company has relocated to a larger space in Zhongguancun Life Science Park Phase III due to rapid growth, necessitating the expansion of its office and laboratory facilities [1] - The new location is expected to accelerate the company's research and development processes [1] Group 2: Industry Growth - Zhongguancun Life Science Park Phase III has attracted 30 companies focused on various fields, including cell and gene therapy, brain science, AI pharmaceuticals, and synthetic biology [1] - The International Precision Medicine Industrial Park, part of the new development, covers an area of 7.4 hectares and includes 242,000 square meters of building space designed to support the pharmaceutical industry's research and development needs [2] - The park has already seen 15 companies complete their entry or sign intentions to move in, with the fastest-moving companies already starting operations [2] Group 3: Infrastructure and Capacity - The development of the Life Valley International Precision Medicine Industrial Park is a testament to the ongoing upgrade of the industrial capacity in Zhongguancun Life Science Park Phase III, releasing 650,000 square meters of industrial space [3] - The Life Valley International Biological Engineering Innovation Center has confirmed or intends to host 15 innovative companies, with some ready to begin internal renovations and expected to move in by April [3] - The new facilities will allow pharmaceutical companies to establish production bases closer to their research and development sites, addressing previous constraints related to space [3] Group 4: Economic Impact - The pharmaceutical and health industry cluster in Changping District is projected to generate 105 billion yuan in revenue by 2025, with seven industrial projects and 47 key projects expected to be established [4] - The ongoing development in Zhongguancun Life Science Park Phase III is anticipated to invigorate this billion-level industry cluster, fostering innovation and growth [4]